SCHEMBL4598193

SCHEMBL4598193

Nc1ccccc1CCNC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.46
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
HIF1A Q16665 1/20 0.43
MTNR1B P49286 1/20 0.42
CA12 O43570 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
EPHX1 P07099 1/20 0.40
PTGS2 P35354 1/20 0.39
PLAAT5 Q96KN8 2/20 0.39
PLAAT4 Q9UL19 2/20 0.39
PLAAT3 P53816 1/20 0.39
PLAAT2 Q9NWW9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27791780 0.89 CYP2D6 (0.45) KDM4EALDH1A1HPGDCYP2D6CYP2C9
Hydrochloric Acid SCHEMBL25337399 0.88 CYP2D6 (0.44) KDM4EALDH1A1HPGDCYP2D6CYP2C9
SCHEMBL17846147 0.88 TRPV1 (0.44) KDM4EALDH1A1HPGDCYP2D6CYP2C9
SCHEMBL15939458 0.87 MTNR1A (0.49) MTNR1AKDM4EALDH1A1HPGDHIF1A
SCHEMBL17846146 0.86 TRPV1 (0.46) HPGDTSHR
SCHEMBL28335010 0.85 MTNR1A (0.63) MTNR1AKDM4EALDH1A1HPGDHIF1A
SCHEMBL28161798 0.84 HIF1A (0.57) MTNR1AALDH1A1HPGDHIF1AMTNR1B
SCHEMBL19031451 0.84 ALDH1A1 (0.40) MTNR1AKDM4EALDH1A1HPGDHIF1A
SCHEMBL3072431 0.84 MTNR1A (0.61) MTNR1AKDM4EMTNR1BCYP1A2TSHR
SCHEMBL6921461 0.81 CYP1A2 (0.49) MTNR1AKDM4EHIF1AMTNR1BCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3750885-A1 COMPOUND HAVING BET INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREFOR Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2020-12-16 EP disclosed
CN-101535276-B 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors CEPHALON INC 2013-08-28 CN disclosed
CN-101535276-A 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors CEPHALON INC (US) 2009-09-16 CN disclosed
EP-1924265-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS Genzyme Corporation (US) 2008-05-28 EP disclosed
EP-1809597-A1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2007-07-25 EP disclosed
WO-2007022371-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORPORATION (US) 2007-02-22 WO disclosed
WO-2006040179-A1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2006-04-20 WO disclosed